Valiant Laboratories Limited EBITDA for the year ending March 31, 2025: USD 88.40 K

Valiant Laboratories Limited EBITDA is USD 88.40 K for the year ending March 31, 2025, a -108.58% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2024 was USD -1.03 M, a -121.21% change year over year.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2023 was USD 4.86 M, a -16.62% change year over year.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2022 was USD 5.83 M, a -16.97% change year over year.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2021 was USD 7.02 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)